Robert E. Dudley

Insider Reports History

Location
Northbrook, IL
Signature
/s/ Steven A. Bourne, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Dudley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Clarus Therapeutics Holdings, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 337,500 12 Dec 2021 Direct
Clarus Therapeutics Holdings, Inc. Chief Executive Officer, Director Common Stock 139,566 12 Dec 2021 Direct

Insider Reports Filed by Robert E. Dudley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRXT Clarus Therapeutics Holdings, Inc. 12 Dec 2021 2 $0 4 Chief Executive Officer, Director 14 Dec 2021, 18:00
CRXT Clarus Therapeutics Holdings, Inc. 09 Sep 2021 1 $0 4 Chief Executive Officer, Director 13 Sep 2021, 20:31
CRXT Clarus Therapeutics Holdings, Inc. 09 Sep 2021 0 $0 3 Chief Executive Officer, Director 13 Sep 2021, 20:29